RSS-Feed abonnieren
DOI: 10.1055/s-0032-1395594
Risk of Bleeding Related to Selective and Non-selective Serotonergic Antidepressants: A Case/Non-case Approach Using Data from Two Pharmacovigilance Databases
Publikationsverlauf
Publikationsdatum:
13. November 2014 (online)
Erratum
Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case/non-case approach using data from two pharmacovigilance databases
1Maximilian Gahr, 1René Zeiss, 2Dirk Lang, 1Bernhard J. Connemann,3Christoph Hiemke, 1Roland W. Freudenmann,1Carlos Schönfeldt-Lecuona
1University of Ulm, Department of Psychiatry and Psychotherapy III, Leimgrubenweg 12-14, 89075 Ulm, Ulm, Germany
2University of Ulm, Department of Psychosomatic Medicine and Psychotherapy, Albert-Einstein-Allee 23, 89081 Ulm, Germany
3 University Medical Center of Mainz, Department of Psychiatry and Psychotherapy, Untere Zahlbacherstr. 8, 55131 Mainz, Mainz, Germany
Pharmacopsychiatry 2014; 47 10.1055/s-0034-1394398
Erratum:
In the abstract, wrong results were erroneously presented for ASS and diclofenac. This error only concerns the reporting odds ratios (ROR) and confidence intervals (CI) of ASS and diclofenac calculated for the BfArM/AkdÄ dataset; ROR and CI calculated for the WHO dataset were correctly presented for both substances in the abstract. Correct results (ROR and CI) for both substances are displayed in table 2 of the article.
The correct results for ASS (to be considered in the abstract) are: BfArM/AkdÄ, ROR 13.71 [95 % CI 12.82–14.66] and for diclofenac: BfArM/AkdÄ, ROR 2.80 [95 % CI 2.59–3.03].